LY-2874455

DB13022InvestigationalSmall molecule

LY2874455 has been used in trials studying the treatment of Advanced Cancer.

Chemical structure of LY-2874455
Mechanism
Curator reviewed
Formula / weight
C21H19Cl2N5O2 · 444.32 g/mol (avg)
Code names
LY2874455

Resolves to

Compound
UNIIE9M363811VCAS1254473-64-7ChEMBLCHEMBL3828009PubChem46944259
Structure
InChIKeyGKJCVYLDJWTWQU-CXLRFSCWSA-NSMILESC[C@@H](OC1=CC=C2NN=C(\C=C\C3=CN(CCO)N=C3)C2=C1)C1=C(Cl)C=NC=C1Cl
Targets
P21802FGFR2

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2874455, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In